Rituximab in people living with hiv affected by immune-mediated renal diseases: a case-series

HIGHLIGHTS

• who: G Alfano and collaborators from the mature, cells expressing , with subsequent decrease of antibody production, RTX has an immunomodulatory effect on both CD4- and CD8-, cells [4-6]Unfortunately, the beneficial effects of RTX-based therapy are offset by a series of unwanted adverse effects including late-onset neutropenia [7-9] , Surgical, Medical and Dental Department of Morphological Sciences, Section of Nephrology, University of Modena and Reggio Emilia, Modena, Italy , Nephrology Dialysis and Transplant Unit, University Hospital of Modena, Modena, Italy , Nephrology and Dialysis Unit, Hospital of Forlu0131u0300-Cesena, Forlu0131u0300-Cesena, Italy , Clinic of Infectious Diseases . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.